XOMA/$XOMA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About XOMA
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
Ticker
$XOMA
Sector
Primary listing
Employees
14
Headquarters
Website
XOMA Metrics
BasicAdvanced
$452m
26.03
$1.46
0.68
-
Price and volume
Market cap
$452m
Beta
0.68
52-week high
$40.74
52-week low
$22.29
Average daily volume
129k
Financial strength
Current ratio
3.368
Quick ratio
3.187
Long term debt to equity
112.125
Total debt to equity
126.544
Dividend payout ratio (TTM)
17.26%
Interest coverage (TTM)
0.87%
Profitability
EBITDA (TTM)
14.356
Gross margin (TTM)
96.72%
Net profit margin (TTM)
60.81%
Operating margin (TTM)
21.83%
Effective tax rate (TTM)
0.32%
Revenue per employee (TTM)
$3,720,000
Management effectiveness
Return on assets (TTM)
2.88%
Return on equity (TTM)
34.12%
Valuation
Price to earnings (TTM)
26.028
Price to revenue (TTM)
8.78
Price to book
5.36
Price to tangible book (TTM)
11.48
Price to free cash flow (TTM)
-19.629
Free cash flow yield (TTM)
-5.09%
Free cash flow per share (TTM)
-1.931
Growth
Revenue change (TTM)
83.06%
Earnings per share change (TTM)
-188.31%
3-year revenue growth (CAGR)
105.30%
10-year revenue growth (CAGR)
-0.61%
3-year earnings per share growth (CAGR)
-9.71%
10-year earnings per share growth (CAGR)
-8.40%
What the Analysts think about XOMA
Analyst ratings (Buy, Hold, Sell) for XOMA stock.
XOMA Financial Performance
Revenues and expenses
XOMA Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for XOMA stock?
XOMA (XOMA) has a market cap of $452M as of April 26, 2026.
What is the P/E ratio for XOMA stock?
The price to earnings (P/E) ratio for XOMA (XOMA) stock is 26.03 as of April 26, 2026.
Does XOMA stock pay dividends?
No, XOMA (XOMA) stock does not pay dividends to its shareholders as of April 26, 2026.
When is the next XOMA dividend payment date?
XOMA (XOMA) stock does not pay dividends to its shareholders.
What is the beta indicator for XOMA?
XOMA (XOMA) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.